| Apoptotic signaling pathways in glioblastoma and therapeutic implications SA Valdés-Rives, D Casique-Aguirre, L Germán-Castelán, ... BioMed research international 2017 (1), 7403747, 2017 | 127 | 2017 |
| KRas4B-PDE6δ complex stabilization by small molecules obtained by virtual screening affects Ras signaling in pancreatic cancer D Casique-Aguirre, P Briseño-Díaz, P García-Gutiérrez, CHG la Rosa, ... BMC cancer 18, 1-16, 2018 | 24 | 2018 |
| Immunological and functional characterization of RhoGDI3 and its molecular targets RhoG and RhoB in human pancreatic cancerous and normal cells MP de León-Bautista, MDC Cardenas-Aguayo, D Casique-Aguirre, ... PLoS One 11 (11), e0166370, 2016 | 19 | 2016 |
| Pranlukast antagonizes cd49f and reduces stemness in triple-negative breast cancer cells I Velázquez-Quesada, AJ Ruiz-Moreno, D Casique-Aguirre, ... Drug Design, Development and Therapy, 1799-1811, 2020 | 13 | 2020 |
| TYK2 variants in B-Acute lymphoblastic leukaemia E Turrubiartes-Martínez, I Bodega-Mayor, P Delgado-Wicke, ... Genes 11 (12), 1434, 2020 | 5 | 2020 |
| Epidemiology of childhood acute leukemias in marginalized populations of the central-south region of Mexico: results from a population-based registry J Flores-Lujano, A Allende-Lopez, DA Duarte-Rodríguez, E Alarcon-Ruiz, ... Frontiers in Oncology 14, 1304263, 2024 | 3 | 2024 |
| Subclassification of B-acute lymphoblastic leukemia according to age, immunophenotype and microenvironment, predicts MRD risk in Mexican children from vulnerable regions R Romo-Rodríguez, G Zamora-Herrera, JA López-Blanco, ... Frontiers in Oncology 13, 2024 | 2 | 2024 |
| Identification of potential inhibitors of SARS-CoV-2 S protein–ACE2 interaction by in silico drug repurposing FE Tristán-Flores, D Casique-Aguirre, R Pliego-Arreaga, ... F1000Research 10, 2021 | 2 | 2021 |
| Implementation of a roadmap for the comprehensive diagnosis, follow-up, and research of childhood leukemias in vulnerable regions of Mexico: results from the PRONAII Strategy JC Núñez-Enríquez, R Romo-Rodríguez, P Gaspar-Mendoza, ... Frontiers in Oncology 14, 1304690, 2024 | 1 | 2024 |
| IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia J Garcia-Solorio, JC Núñez-Enriquez, M Jiménez-Olivares, ... Frontiers in Oncology 14, 1337954, 2024 | 1 | 2024 |
| The Platelet Serotonergic System and the Search for New Biomarkers and Therapeutic Options for Diverse Diseases A Briones-Aranda, J Corzo-Gómez, D Casique-Aguirre, ... Serotonin-Neurotransmitter and Hormone of Brain, Bowels and Blood, 2023 | 1 | 2023 |
| Identificación y evaluación in silico, in vitro e in vivo de pequeñas moléculas que estabilizan el complejo molecular KRas4B-PDEdelta D Casique Aguirre Tesis (DC)--Centro de Investigación y de Estudios Avanzados del IPN …, 2016 | 1 | 2016 |
| Virtual screening for potential inhibitors of the molecular interaction of SARS‐CoV‐2 binding to the ACE2 receptor G Silva‐Martinez, F Tristan‐Flores, R Pineda‐Silva, G Acosta‐García, ... The FASEB Journal 35, 2021 | | 2021 |
| Structure-based virtual screening identifies pranlukast as a CD49f antagonist that reduces stemness in MDA-MB-231 breast cancer cells M Velasco-Velazquez, I Velazquez-Quesada, A Ruiz-Moreno, ... BRITISH JOURNAL OF CANCER 119 (11), 46-46, 2018 | | 2018 |
| Identification and Evaluation in silico and in vitro of Small Molecules in the KRas4B‐PDEδ Molecular Complex in Pancreatic Cancer DC Aguirre, PG Gutiérrez, MP de León Bautista, MÁV Mejía The FASEB Journal 30, 937.9-937.9, 2016 | | 2016 |
| Facebook Page MAV Mejia, P Briseño-Diaz, D Casique-Aguirre, P Cruz-Nova, ... | | |